BB BIOTECH N 2. LINIE overview

ULURU Inc. Announces Closing Of $6,000,000 Financing PR Newswire ADDISON, Texas, April 3, 2017 ADDISON, Texas , April 3, 2017 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR), a specialty medical technology company focused on the development of a portfolio of wound management and oral drug delivery products, today announced it has completed the second closing under the Note, Warrant and Preferred Stock Purchase Agreement with Velocitas Partners, LLC and its affiliates (collectively "Velocitas") under...

ULURU Inc. Announces Strategic Financing Agreement PR Newswire ADDISON, Texas, Feb. 28, 2017 ADDISON, Texas , Feb. 28, 2017 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR), a specialty medical technology company focused on the development of a portfolio of wound management and oral drug delivery products, today announced it has entered into a Note, Warrant and Preferred Stock Purchase Agreement with Velocitas Partners, LLC and its affiliates ("Velocitas") under which the Company is expected to receive...

ULURU Inc. Reports Financial Results For Third Quarter 2016 PR Newswire ADDISON, Texas, Nov. 14, 2016 ADDISON, Texas , Nov. 14, 2016 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced its financial results for the third quarter ended September 30, 2016 and provided a review of its operating activities. Commenting on ULURU Inc. (the "Company") activities, Helmut Kerschbaumer , Interim President and CEO, stated, "Building on the licensing agreements we announced last quarter; namely Saraya...